美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

康休

65.60

+0.0000

成交量：- -

成交額：- -

市值：127.60億

市盈率：-1.26

高：65.60

開：65.60

低：65.60

收：65.60

資料載入中...

總覽公司新聞公告

Particle Network、Haedal Protocol出席“OKX Web3 Night”

港股異動 | CRO概念股跌幅居前機構稱關税對CXO及上游目前影響較為有限關注生物安全法案相關進展

CXO企業國內營收集體“首降” 五大龍頭淨利潤全線下滑拐點漸顯至暗時刻已過？

A股收評：三大指數小幅收漲全市場成交額不足萬億元

現金方式收購CXO企業賬上錢夠嗎？成都先導回應

現金方式收購CXO企業，賬上錢夠嗎？成都先導回應

21世纪经济报道

港股異動 | CRO概念股漲幅居前全鏈條支持創新藥發展政策逐步落地機構稱有望拉動CXO需求

地量震盪，什麼原因？化工板塊領跌，券商護盤未果！CXO突然變臉，醫療ETF（512170）溢價仍走高

業績向好，CXO復甦進程開啓？藥明康德、康龍化成聯袂大漲醫療ETF(512170)放量漲1.18% 尾盤溢價飆升

久違了，“喫藥喝酒”行情，CXO強勢助攻！AI芯片點火，科創人工智能ETF華寶（589520）盤中衝擊3%！

【港股CXO板塊集體走強，藥明康德漲超4%】維亞生物漲超7%，昭衍新藥、藥明生物漲超6%，康龍化成、藥明康德漲超4%，泰格醫藥、凱萊英漲超3%，金斯瑞生物科技漲超2%。

業績揭曉，康龍化成勁漲3%，CXO概念集體反彈！醫療ETF（512170）拉昇翻紅，此前5日大舉吸金6.3億元！

藥明生物(02269)年報觀：“低估值+高成長”，全球CXO龍頭估值亟待強修復

官宣10億元註銷式回購！藥明康德績後一度漲停，CXO概念集體響應，醫療ETF（512170）放量摸高2.56%！

港股收評：恒生科技指數大漲近4% 機器人概念股午後強勢拉昇

港股CXO概念股盤初走強，藥明康德漲超13%

每日经济新闻

港股異動 | CRO概念股回暖 AI+CXO融合進入新階段機構稱CRO外部環境或有好轉

11家印度CXO抱團搶單，三星、富士拱火，中國"藥明"們頂得住嗎？

“AI+”強勢迴歸，醫療ETF（512170）放量拉漲1.45%！CXO概念股集體衝高，巨頭藥明康德大漲3.5%

【海通證券：DeepSeek時刻，關注創新藥和AI醫療的機會】海通證券認為，DeepSeek帶來了市場對AI行業的關注，有較強的數據整合實力的應用公司是這一輪AI+醫藥的關注點，需要考慮創造新場景以及原有需求下降本增效的商業可能的路徑，建議關注在醫療入口級創造新場景的公司。海通證券認為，隨着全鏈條支持創新藥產業發展的政策提出，各種配套政策也在陸續落地，展望未來，一方面期待政策為真創新的藥物提供良好的發展空間，另一方面看好醫保局和商保公司的協作，通力打造1+3+n的多層次醫療保障體系，打開支付端新空間，建議關注產業鏈的機會。海通證券認為，消費需求邊際回暖，建議關注板塊龍頭。綜上，在3月月度組合的配置上，重點關注創新藥/CXO（創新藥產業鏈）、醫療服務（消費+AI）、互聯網醫療（AI）的相關機會。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CXO/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"康休","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"退市","change":0,"latestTime":"04-07 13:01:55 EDT","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1744056000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525063861","title":"Particle Network、Haedal Protocol出席“OKX Web3 Night”","url":"https://stock-news.laohu8.com/highlight/detail?id=2525063861","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525063861?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 13:52","pubTimestamp":1744005174,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据官方消息，“OKX Web3 Night”活动于 4 月 6 日正式开启，现场气氛火热。Particle Network/UniversalX CXO Lydia 、Haedal 创始人 Luke，以及 OKX 全球首席商务官 Lennix 出席了活动，围绕《距离全民 Web3，还有多远？》主题，展开了一场深度圆桌对话。\nLuke 表示，TGE 对项目来说是构建社区，增长用户的重要机会。但从 DeFi 项目的整个生命周期来看，TGE 只是开始使用 tokenomics 构建完整产品的“成人时刻”。有坚实产品和强大营收的项目将获得市场认可和公允定价。此外，Luke 透露，Haedal protocol 将于四月 TGE。Lydia 认为，所有有真正 PMF 的 DApp 都值得用链抽象的方式再做一遍。UniversalX 会与 OKX 钱包一同探索非托管前提下的最优多链用户体验。\n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/426072?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK7504","BK7095","PMF","CXO.AU","CXO"],"gpt_icon":0},{"id":"2525036363","title":"港股異動 | CRO概念股跌幅居前 機構稱關税對CXO及上游目前影響較為有限 關注生物安全法案相關進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2525036363","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525036363?lang=zh_tw&edition=fundamental","pubTime":"2025-04-07 10:03","pubTimestamp":1743991390,"startTime":"0","endTime":"0","summary":"本次美国对中国加征关税中，药品暂不涉及。该行指出，国内CXO行业目前在研发阶段主要以研发服务形式对美出口，属于免关税。国内“对等关税”出台预计同样对行业整体影响较小。西南证券指出，CXO关注生物安全法案相关进展。中泰国际此前表示，美国在今年出台的《2025财年国防授权法案》中暂未提及生物安全法案，根据近期在医药行业的多方了解，按目前情况预计2025年内出台生物安全法案的可能性不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1274420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","03759","BK1141","BK1576","BK1583","CXO","01873","06127"],"gpt_icon":0},{"id":"2524018864","title":"CXO企業國內營收集體“首降” 五大龍頭淨利潤全線下滑 拐點漸顯至暗時刻已過？","url":"https://stock-news.laohu8.com/highlight/detail?id=2524018864","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524018864?lang=zh_tw&edition=fundamental","pubTime":"2025-04-03 13:50","pubTimestamp":1743659400,"startTime":"0","endTime":"0","summary":"　　2024年，中国CXO行业交出了一份并不理想的成绩单。药明康德、康龙化成、泰格医药、凯莱英、博腾股份五大头部企业净利润全线下滑。　　泰格医药营收同比下降超10%，归母净利润、扣非净利润分别下滑79.99%、42.13%，均创下历史最大跌幅。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-04-03/doc-inerwmtp8492751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO"],"gpt_icon":0},{"id":"2524349433","title":"A股收評：三大指數小幅收漲 全市場成交額不足萬億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524349433","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524349433?lang=zh_tw&edition=fundamental","pubTime":"2025-04-02 15:04","pubTimestamp":1743577466,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["CXO.AU","399001","BK0077","BK0034","002006","161121","603178","BK0264","CXO","BK0102","BK7095","159982","399006","BK1128","159940","399300","BK7504","603072","BK0251","605228","01981","BK0054","BK0064","BK0214"],"gpt_icon":0},{"id":"2524134642","title":"現金方式收購CXO企業 賬上錢夠嗎？成都先導回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2524134642","media":"美港电讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524134642?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 12:56","pubTimestamp":1743483375,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["CXO","09939","BK7095","BK0216","CXO.AU","688222","159938","BK1161","BK7504","BK1574","BK1515"],"gpt_icon":0},{"id":"2524132571","title":"現金方式收購CXO企業，賬上錢夠嗎？成都先導回應","url":"https://stock-news.laohu8.com/highlight/detail?id=2524132571","media":"21世纪经济报道","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524132571?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 12:51","pubTimestamp":1743483060,"startTime":"0","endTime":"0","summary":"3月31日晚间，成都先导公告称，公司正在筹划以现金方式受让股权的方式合计取得南京海纳医药科技股份有限公司约65%的股权。目前，成都先导与海纳医药尚未就收购的具体方案、最终股权比例、交易价格、业绩承诺等达成一致意见，收购尚处于筹划阶段。成都先导预计将于6个月内披露交易的预案或正式方案。截至4月1日早盘收盘，成都先导涨12.07%，报17.36元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-04-01/doc-inerrtfn7385403.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-01/doc-inerrtfn7385403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","688222","CXO"],"gpt_icon":0},{"id":"2524180722","title":"港股異動 | CRO概念股漲幅居前 全鏈條支持創新藥發展政策逐步落地 機構稱有望拉動CXO需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2524180722","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524180722?lang=zh_tw&edition=fundamental","pubTime":"2025-04-01 11:02","pubTimestamp":1743476525,"startTime":"0","endTime":"0","summary":"中信建投此前指出，近年来在ADC、多肽药物快速发展下，相关CXO需求迅速增加，小核酸、CGT等细分领域也有望迎来快速发展。长期仍看好CXO板块发展潜力及成长空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1272405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456846285.SGD","BK1161","BK1141","LU0516422440.USD","LU0043850808.USD","LU0140636845.USD","SG9999002562.SGD","LU0588546209.SGD","LU0051755006.USD","BK1521","06978","LU0052750758.USD","LU0979878070.USD","BK1191","LU2039709279.SGD","LU0417516738.SGD","LU1880383366.USD","LU0516423091.SGD","LU0417516902.SGD","BK1576","LU1242518857.USD","LU0456827905.SGD","BK1589","LU0823426308.USD","LU1688375341.USD","IE00B0JY6N72.USD","LU0708995583.HKD","LU0307460666.USD","LU0320764599.SGD","LU0039217434.USD","LU0348735423.USD","LU1242518931.SGD","LU1720050803.USD","LU0823426480.USD","BK1574","02269","LU0348825331.USD","06127","LU0326950275.SGD","LU0181495838.USD","LU0572944931.SGD","06821","LU0856984785.SGD","LU0516422366.SGD","LU0516422952.EUR","159992","CXO","BK1610","LU0359201612.USD","03759"],"gpt_icon":1},{"id":"2522764625","title":"地量震盪，什麼原因？化工板塊領跌，券商護盤未果！CXO突然變臉，醫療ETF（512170）溢價仍走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2522764625","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522764625?lang=zh_tw&edition=fundamental","pubTime":"2025-03-28 20:23","pubTimestamp":1743164580,"startTime":"0","endTime":"0","summary":"周五，A股再续调整，三大指数跌幅均超0.5%，全市场缩量成交1.15万亿元，单日成交额创2月以来新低。化工板块领跌，化工ETF场内跌1.27%。CXO掉头向下，引发医药医疗冲高回落，医疗ETF场内跌0.87%。券商板块午后一度直线拉升翻红，终究难敌抛压，券商ETF平盘报收。　　【CXO突然变脸，泰格医药绩后重挫6.6%！　　A股普跌影响下，医疗板块震荡走低，医疗ETF早盘一度逆市翻红，而后持续下行，场内收跌0.87%，振幅超2%，成交5.84亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-28/doc-inerfitm1180488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","159828","512170"],"gpt_icon":0},{"id":"2522301714","title":"業績向好，CXO復甦進程開啓？藥明康德、康龍化成聯袂大漲 醫療ETF(512170)放量漲1.18% 尾盤溢價飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301714","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301714?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 21:33","pubTimestamp":1743082380,"startTime":"0","endTime":"0","summary":"3月27日，医疗板块在CXO强力带动下震荡走高，医疗ETF早盘成功翻红，午后高位盘整，场内收涨1.18%，全天振幅达2.65%，放量成交6亿元。　　值得关注的是，尾盘医疗ETF溢价走阔，反映买盘资金尤为强势。而此前5日已有资金连续进场，累计净申购逾6.3亿元。　　成份股表现来看，CXO概念股涨幅居前，昭衍新药、博腾股份涨超5%领涨板块，泰格医药、康龙化成涨超4%，巨头药明康德涨3.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-inerceui7893938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03759","LU0052750758.USD","BK0216","LU1997245177.USD","LU2045819591.USD","LU1997245094.SGD","BK1576","CXO","LU0320764599.SGD","LU2125910500.SGD","LU0456842615.SGD","LU1046422090.SGD","BK1583","LU0708995583.HKD","603259","LU2242644610.SGD","LU2488822045.USD","512170","159828","BK1141","02359","300759"],"gpt_icon":0},{"id":"2522301075","title":"久違了，“喫藥喝酒”行情，CXO強勢助攻！AI芯片點火，科創人工智能ETF華寶（589520）盤中衝擊3%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301075","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301075?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 21:32","pubTimestamp":1743082320,"startTime":"0","endTime":"0","summary":"三大指数早盘联袂拉涨，午后横盘运行，均以红盘报收。权重股回暖，核心龙头宽基A50ETF华宝跑赢大市。　　盘面上，“吃药喝酒”行情久违再现！　　半导体芯片全线走强，芯原股份、力合微等AI芯片龙头领头飙升，科创人工智能ETF华宝盘中冲击3%！重点布局国产AI产业链的科创人工智能ETF华宝场内价格今日再涨1.42%，斩获日线2连阳！上交所数据显示，科创人工智能ETF华宝近10日累计吸金5233万元！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-inerceui7893562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["588730","CXO"],"gpt_icon":0},{"id":"2522731276","title":"【港股CXO板塊集體走強，藥明康德漲超4%】維亞生物漲超7%，昭衍新藥、藥明生物漲超6%，康龍化成、藥明康德漲超4%，泰格醫藥、凱萊英漲超3%，金斯瑞生物科技漲超2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2522731276","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522731276?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 14:55","pubTimestamp":1743058528,"startTime":"0","endTime":"0","summary":"维亚生物涨超7%，昭衍新药、药明生物涨超6%，康龙化成、药明康德涨超4%，泰格医药、凯莱英涨超3%，金斯瑞生物科技涨超2%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c1d06c6940354aa092ba4cb0febc291a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/27145549081529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0456827905.SGD","BK1576","LU0039217434.USD","02269","BK0239","LU0819121731.USD","BK1610","CXO","LU1997245177.USD","BK1583","LU0572944931.SGD","603259","03759","HSCEI","LU1688375341.USD","LU2039709279.SGD","01548","01873","LU0181495838.USD","BK1589","LU0051755006.USD","03347","BK1191","LU2242644610.SGD","002821","LU1146622755.USD","YANG","LU0348735423.USD","HSTECH","BK0077","603127","LU1820825898.SGD","LU1997245094.SGD","LU0516423091.SGD","300759","06821","BK4614","LU0043850808.USD","LU0979878070.USD","HK0000306685.HKD","02359","LU2488822045.USD","LU1794554557.SGD","LU1720050803.USD","300347","LU1046422090.SGD","LU0516422952.EUR","06127","LU0456846285.SGD"],"gpt_icon":0},{"id":"2522971763","title":"業績揭曉，康龍化成勁漲3%，CXO概念集體反彈！醫療ETF（512170）拉昇翻紅，此前5日大舉吸金6.3億元！","url":"https://stock-news.laohu8.com/highlight/detail?id=2522971763","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522971763?lang=zh_tw&edition=fundamental","pubTime":"2025-03-27 11:29","pubTimestamp":1743046140,"startTime":"0","endTime":"0","summary":"3月27日早盘，医疗板块盘中拉升，医疗ETF成功翻红，成份股中CXO概念股涨幅居前，博腾股份涨超6%领涨板块，昭衍新药涨4%了， 泰格医药、康龙化成涨超3%。　　近期医疗资金面热度攀升，数据显示，此前5个交易日，医疗ETF场内连续申赎净流入，金额合计超6.3亿元。　　消息面，康龙化成最新公布2024年年报，公司营业收入122.8亿元，同比上升6.4%；归母净利润17.9亿元，同比上升12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-27/doc-ineraiqq4036116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300759","159828","512170","BK1141","BK1576","03759","BK0216","CXO"],"gpt_icon":0},{"id":"2522247700","title":"藥明生物(02269)年報觀：“低估值+高成長”，全球CXO龍頭估值亟待強修復","url":"https://stock-news.laohu8.com/highlight/detail?id=2522247700","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522247700?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 19:53","pubTimestamp":1742903616,"startTime":"0","endTime":"0","summary":"2024年，全球多数头部CXO公司陆续下调了业绩指引，但即便如此最终达成年初业绩指引的也只是少数。在此业绩导向下，药明生物在2025年回归高增速增长的确定性明显提高，公司估值有望实现强修复并回到正常增长轨道，预计2025年整体收入增长12-15%。此外，药明生物在2024年下半年PPQ先导指标回归高增长，全年完成16个PPQ项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348735423.USD","LU0051755006.USD","LU1880383366.USD","LU0588546209.SGD","LU0979878070.USD","SG9999002463.SGD","LU0326950275.SGD","LU0708995583.HKD","BK1141","SG9999002562.SGD","LU0823426480.USD","LU0327786744.USD","LU0856984785.SGD","LU1688375341.USD","LU1794554557.SGD","LU0456846285.SGD","IE00B0JY6N72.USD","LU0516422440.USD","LU0359202008.SGD","LU0417516902.SGD","LU0320764599.SGD","LU0039217434.USD","LU0043850808.USD","LU0052750758.USD","LU0348825331.USD","LU1242518857.USD","BK1521","LU0456827905.SGD","BK1610","LU0516422952.EUR","LU0516423174.USD","LU0140636845.USD","LU0417516738.SGD","BK1589","LU2039709279.SGD","LU1242518931.SGD","LU0181495838.USD","LU0516423091.SGD","LU0307460666.USD","LU0516422366.SGD","LU0819121731.USD","LU1720050803.USD","CXO","BK1576","02269","LU0359201612.USD","LU0572944931.SGD","LU0823426308.USD"],"gpt_icon":1},{"id":"2520678336","title":"官宣10億元註銷式回購！藥明康德績後一度漲停，CXO概念集體響應，醫療ETF（512170）放量摸高2.56%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2520678336","media":"市场资讯","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520678336?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 20:12","pubTimestamp":1742299920,"startTime":"0","endTime":"0","summary":"　　3月18日，药明康德绩后大涨，一呼百应！CXO集体上攻，带动医疗板块强势反弹，场内热门医疗ETF盘中摸高2.56%，场内收涨1.71%，全天成交7.93亿元，较昨日放量1.8亿元。　　值得关注的是，近期医疗ETF资金面火热，截至昨日，近5日申赎净流入逾1亿元，近10日累计吸金超5.28亿元。药明康德今日跳空高开，早盘一度涨停，收涨8.82%创近1年新高，总市值升至2000亿元！","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-18/doc-ineqautk5564032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1997245177.USD","LU1046422090.SGD","CXO","LU1997245094.SGD","LU2045819591.USD","LU2242644610.SGD","LU0456842615.SGD","BK1583","603259","LU0320764599.SGD","LU2488822045.USD","LU0052750758.USD","BK0216","159828","LU2125910500.SGD","BK1141","BK1576","512170","02359","LU0708995583.HKD"],"gpt_icon":1},{"id":"2520180136","title":"港股收評：恒生科技指數大漲近4% 機器人概念股午後強勢拉昇","url":"https://stock-news.laohu8.com/highlight/detail?id=2520180136","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520180136?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 16:15","pubTimestamp":1742285741,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0594300419.USD","02015","EVS.SI","HSI","000333","BK4077","02833","02359","160636","HSTECH","MCHmain","HBBD.SI","HSImain","BK1588","LU2152927971.USD","BABA","LU1880398554.USD","HHImain","02432","09901","LU0648000940.SGD","HSCEI","CXO.AU","MHImain","BK4588","00300","LU2242644610.SGD","LU0359201612.USD","LU1642822792.SGD","LU0149721374.USD","LU0791590937.USD","603259","LU0572944931.SGD","EDU","BK1609","07226","LU1720051108.HKD","YANG","89988","CXO","LU0307460666.USD","09888","159792","09866","89888","LI","BIDU","513600","09988","LU1366334651.USD"],"gpt_icon":0},{"id":"2520234658","title":"港股CXO概念股盤初走強，藥明康德漲超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520234658","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520234658?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 09:45","pubTimestamp":1742262336,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月18日，港股CXO概念股盘初走强，药明康德涨超13%，药明生物涨超8%，康龙化成、泰格医药、昭衍新药纷纷拉升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://stock.eastmoney.com/a/202503183348606777.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202503183348606777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2045819591.USD","BK1141","LU0708995583.HKD","HSCEI","BK1576","LU0320764599.SGD","BK1583","LU1046422090.SGD","02359","HSTECH","LU2242644610.SGD","BK4614","YANG","CXO","LU2125910500.SGD","LU0052750758.USD"],"gpt_icon":0},{"id":"2519181628","title":"港股異動 | CRO概念股回暖 AI+CXO融合進入新階段 機構稱CRO外部環境或有好轉","url":"https://stock-news.laohu8.com/highlight/detail?id=2519181628","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519181628?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 10:47","pubTimestamp":1741920477,"startTime":"0","endTime":"0","summary":"国泰君安指出，DeepSeek等通用大模型在蛋白质折叠预测准确率突破90%，叠加生成式AI实现分子结构生成效率提升5-8倍，推动AI+CXO融合进入新阶段。全球药企降本增效诉求升级，叠加AI技术成熟度提升，驱动CXO企业加速智能化转型。此外，预计更多CRO企业将积极拥抱AI技术，以寻求在竞争激烈的市场中提升竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1261809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0417516738.SGD","LU0307460666.USD","LU1688375341.USD","LU0456827905.SGD","LU0572944931.SGD","LU0516423174.USD","LU0320764599.SGD","03347","LU0819121731.USD","LU0588546209.SGD","LU0823426308.USD","LU0516422440.USD","LU0348825331.USD","LU0708995583.HKD","BK1610","LU0181495838.USD","LU0051755006.USD","LU0359201612.USD","SG9999002463.SGD","BK1589","LU0140636845.USD","LU0823426480.USD","LU1242518857.USD","LU1880383366.USD","LU2039709279.SGD","LU0327786744.USD","LU0979878070.USD","LU0359202008.SGD","BK1141","LU1242518931.SGD","02269","LU0456846285.SGD","LU0052750758.USD","LU0516423091.SGD","IE00B0JY6N72.USD","LU1794554557.SGD","LU0043850808.USD","LU0326950275.SGD","LU0348735423.USD","SG9999002562.SGD","LU0417516902.SGD","BK1521","CXO","LU0516422366.SGD","LU0039217434.USD","BK1576","LU0516422952.EUR","03759","BK1583","01873"],"gpt_icon":1},{"id":"2517197122","title":"11家印度CXO抱團搶單，三星、富士拱火，中國\"藥明\"們頂得住嗎？","url":"https://stock-news.laohu8.com/highlight/detail?id=2517197122","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517197122?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 21:25","pubTimestamp":1741267525,"startTime":"0","endTime":"0","summary":"爱掉链子的印度CXO，是狼还是羊？据穆迪印度子公司评级机构ICRA Limited的估算，十年后，印度对中国原料药的依赖将减少35%。最终的目的，自然是进一步提升印度CRDMO的国别竞争力，与中国分庭抗礼，乃至替代。乐观者则认为，印度CDMO公司尚无法对于中国同业进行有效替代。2024年前三季度，药明康德新增客户超过800家，维持现有超过6000家活跃客户群。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035701abebc5b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035701abebc5b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FUJIY","BK4170","CXO"],"gpt_icon":0},{"id":"2517903108","title":"“AI+”強勢迴歸，醫療ETF（512170）放量拉漲1.45%！CXO概念股集體衝高，巨頭藥明康德大漲3.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517903108","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517903108?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 10:39","pubTimestamp":1741228740,"startTime":"0","endTime":"0","summary":"3月6日早盘，医疗板块全线反弹，CXO、AI医疗概念联袂领涨！博腾股份涨超5%，卫宁健康、药明康德涨超3.5%，康龙化成、昭衍新药、泰格医药等大幅跟涨。　　ETF方面，医疗ETF震荡走高，现涨1.45%，成交额突破3.6亿元。值得关注的是，昨日板块调整区间医疗ETF获大额资金逢跌增仓， 单日申赎净流入逾1.5亿元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-03-06/doc-inensrzm8043862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0320764599.SGD","512170","LU2242644610.SGD","159828","LU1997245177.USD","LU2488822045.USD","CXO","LU2045819591.USD","LU1046422090.SGD","LU0456842615.SGD","BK1576","LU1997245094.SGD","LU2125910500.SGD","02359","BK1141","BK0216","LU0052750758.USD","603259","LU0708995583.HKD","BK1583"],"gpt_icon":0},{"id":"2516669826","title":"【海通證券：DeepSeek時刻，關注創新藥和AI醫療的機會】海通證券認為，DeepSeek帶來了市場對AI行業的關注，有較強的數據整合實力的應用公司是這一輪AI+醫藥的關注點，需要考慮創造新場景以及原有需求下降本增效的商業可能的路徑，建議關注在醫療入口級創造新場景的公司。海通證券認為，隨着全鏈條支持創新藥產業發展的政策提出，各種配套政策也在陸續落地，展望未來，一方面期待政策為真創新的藥物提供良好的發展空間，另一方面看好醫保局和商保公司的協作，通力打造1+3+n的多層次醫療保障體系，打開支付端新空間，建議關注產業鏈的機會。海通證券認為，消費需求邊際回暖，建議關注板塊龍頭。綜上，在3月月度組合的配置上，重點關注創新藥/CXO（創新藥產業鏈）、醫療服務（消費+AI）、互聯網醫療（AI）的相關機會。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516669826","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516669826?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:07","pubTimestamp":1741046840,"startTime":"0","endTime":"0","summary":"海通证券认为，DeepSeek带来了市场对AI行业的关注，有较强的数据整合实力的应用公司是这一轮AI+医药的关注点，需要考虑创造新场景以及原有需求下降本增效的商业可能的路径，建议关注在医疗入口级创造新场景的公司。综上，在3月月度组合的配置上，重点关注创新药/CXO、医疗服务、互联网医疗的相关机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04080748499540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159891","09939","06837","159938","159992","CXO","06978","600837"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"盤後","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.325388,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[{"date":"2020-04-09","current":-14.604236,"twenty":-14.688413,"median":33.876704,"eighty":51.321549,"marketCap":10295986129},{"date":"2020-04-17","current":-14.382708,"twenty":-14.693919,"median":33.652944,"eighty":50.675163,"marketCap":10139808865},{"date":"2020-04-24","current":-14.701154,"twenty":-14.719228,"median":33.451617,"eighty":50.252118,"marketCap":10364313682},{"date":"2020-05-01","current":-1.19246,"twenty":-14.900412,"median":33.010351,"eighty":49.874618,"marketCap":11074376079},{"date":"2020-05-08","current":-1.232608,"twenty":-14.900412,"median":29.923023,"eighty":49.729928,"marketCap":11447230976},{"date":"2020-05-15","current":-1.140541,"twenty":-14.900412,"median":28.505604,"eighty":49.729928,"marketCap":10592202468},{"date":"2020-05-22","current":-1.173542,"twenty":-14.900412,"median":27.9469,"eighty":49.729928,"marketCap":10898685290},{"date":"2020-05-29","current":-1.146006,"twenty":-14.900412,"median":27.733111,"eighty":49.729928,"marketCap":10642957585},{"date":"2020-06-05","current":-1.476649,"twenty":-14.900412,"median":27.185707,"eighty":49.729928,"marketCap":13713642157},{"date":"2020-06-12","current":-1.219155,"twenty":-14.900412,"median":26.906303,"eighty":49.729928,"marketCap":11322295304},{"date":"2020-06-19","current":-1.166606,"twenty":-14.900412,"median":26.678555,"eighty":49.729928,"marketCap":10834265334},{"date":"2020-06-26","current":-1.057302,"twenty":-14.900412,"median":26.223249,"eighty":49.729928,"marketCap":9819162996},{"date":"2020-07-02","current":-1.081895,"twenty":-14.900412,"median":26.100817,"eighty":49.729928,"marketCap":10047561022},{"date":"2020-07-10","current":-1.035021,"twenty":-14.900412,"median":25.811921,"eighty":49.729928,"marketCap":9612238289},{"date":"2020-07-17","current":-1.060245,"twenty":-14.900412,"median":25.495623,"eighty":49.729928,"marketCap":9846492674},{"date":"2020-07-24","current":-1.123725,"twenty":-14.900412,"median":25.400075,"eighty":49.729928,"marketCap":10436032878},{"date":"2020-07-31","current":-1.066588,"twenty":-14.900412,"median":25.179654,"eighty":49.536695,"marketCap":10265909235},{"date":"2020-08-07","current":-1.040806,"twenty":-14.900412,"median":24.527679,"eighty":48.902121,"marketCap":10017761067},{"date":"2020-08-14","current":-1.040603,"twenty":-14.900412,"median":24.088548,"eighty":48.654643,"marketCap":10015807145},{"date":"2020-08-21","current":-0.984371,"twenty":-14.900412,"median":23.757593,"eighty":48.04925,"marketCap":9474570590},{"date":"2020-08-28","current":-1.060904,"twenty":-14.900412,"median":23.237709,"eighty":48.005982,"marketCap":10211199403},{"date":"2020-09-04","current":-1.02822,"twenty":-14.900412,"median":22.879248,"eighty":47.833642,"marketCap":9896617867},{"date":"2020-09-11","current":-0.919815,"twenty":-14.900412,"median":22.710048,"eighty":47.357651,"marketCap":8853223209},{"date":"2020-09-18","current":-0.976251,"twenty":-14.900412,"median":22.487665,"eighty":46.705482,"marketCap":9396413687},{"date":"2020-09-25","current":-0.887335,"twenty":-14.900412,"median":22.044459,"eighty":45.673114,"marketCap":8540595597},{"date":"2020-10-02","current":-0.874342,"twenty":-14.900412,"median":21.695329,"eighty":45.308472,"marketCap":8415544552},{"date":"2020-10-09","current":-0.914131,"twenty":-14.900412,"median":21.325904,"eighty":45.001416,"marketCap":8798513377},{"date":"2020-10-16","current":-0.986604,"twenty":-14.900412,"median":20.472618,"eighty":44.616144,"marketCap":9496063738},{"date":"2020-10-23","current":-0.951552,"twenty":-14.900412,"median":20.050952,"eighty":44.013784,"marketCap":9158686969},{"date":"2020-10-30","current":-0.788207,"twenty":-14.900412,"median":19.603963,"eighty":43.678027,"marketCap":8074392990},{"date":"2020-11-06","current":-0.804917,"twenty":-14.900412,"median":19.294145,"eighty":43.599353,"marketCap":8245567787},{"date":"2020-11-13","current":-0.972584,"twenty":-14.900412,"median":18.943416,"eighty":43.599353,"marketCap":9963151264},{"date":"2020-11-20","current":-1.090882,"twenty":-14.900412,"median":18.315824,"eighty":43.599353,"marketCap":11174991021},{"date":"2020-11-27","current":-1.177658,"twenty":-14.900412,"median":18.027808,"eighty":43.599353,"marketCap":12063932866},{"date":"2020-12-04","current":-1.22361,"twenty":-14.900412,"median":17.915245,"eighty":43.599353,"marketCap":12534663558},{"date":"2020-12-11","current":-1.201394,"twenty":-14.900412,"median":17.827972,"eighty":43.599353,"marketCap":12307078885},{"date":"2020-12-17","current":-1.169683,"twenty":-14.906009,"median":17.756409,"eighty":43.604534,"marketCap":11982235804},{"date":"2020-12-24","current":-1.091261,"twenty":-14.911606,"median":17.634394,"eighty":43.609716,"marketCap":11178881358},{"date":"2020-12-31","current":-1.106262,"twenty":-14.920934,"median":17.601937,"eighty":43.610988,"marketCap":11332549641},{"date":"2021-01-08","current":-1.237472,"twenty":-14.937462,"median":17.527755,"eighty":43.624979,"marketCap":12676660833},{"date":"2021-01-15","current":-1.325388,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"marketCap":13577273687}],"updateTime":1744006092817}}}